BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 28982499)

  • 1. Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.
    Lam PH; Dooley DJ; Deedwania P; Singh SN; Bhatt DL; Morgan CJ; Butler J; Mohammed SF; Wu WC; Panjrath G; Zile MR; White M; Arundel C; Love TE; Blackman MR; Allman RM; Aronow WS; Anker SD; Fonarow GC; Ahmed A
    J Am Coll Cardiol; 2017 Oct; 70(15):1861-1871. PubMed ID: 28982499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
    Lam PH; Packer M; Gill GS; Wu WC; Levy WC; Zile MR; Brar V; Arundel C; Cheng Y; Singh SN; Allman RM; Fonarow GC; Ahmed A
    Am J Med; 2020 Oct; 133(10):1187-1194. PubMed ID: 32272101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.
    Tsimploulis A; Lam PH; Arundel C; Singh SN; Morgan CJ; Faselis C; Deedwania P; Butler J; Aronow WS; Yancy CW; Fonarow GC; Ahmed A
    JAMA Cardiol; 2018 Apr; 3(4):288-297. PubMed ID: 29450487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
    Malik A; Masson R; Singh S; Wu WC; Packer M; Pitt B; Waagstein F; Morgan CJ; Allman RM; Fonarow GC; Ahmed A
    J Am Coll Cardiol; 2019 Aug; 74(5):617-627. PubMed ID: 31370952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate.
    Lam PH; Gupta N; Dooley DJ; Singh S; Deedwania P; Zile MR; Bhatt DL; Morgan CJ; Pitt B; Fonarow GC; Ahmed A
    Am J Med; 2018 Dec; 131(12):1473-1481. PubMed ID: 30076815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure.
    Bhatia V; Bajaj NS; Sanam K; Hashim T; Morgan CJ; Prabhu SD; Fonarow GC; Deedwania P; Butler J; Carson P; Love TE; Kheirbek R; Aronow WS; Anker SD; Waagstein F; Fletcher R; Allman RM; Ahmed A
    Am J Med; 2015 Jul; 128(7):715-21. PubMed ID: 25554369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior Heart Failure Hospitalization and Outcomes in Patients with Heart Failure with Preserved and Reduced Ejection Fraction.
    Malik A; Gill GS; Lodhi FK; Tummala LS; Singh SN; Morgan CJ; Allman RM; Fonarow GC; Ahmed A
    Am J Med; 2020 Jan; 133(1):84-94. PubMed ID: 31336093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
    Arundel C; Lam PH; Gill GS; Patel S; Panjrath G; Faselis C; White M; Morgan CJ; Allman RM; Aronow WS; Singh SN; Fonarow GC; Ahmed A
    J Am Coll Cardiol; 2019 Jun; 73(24):3054-3063. PubMed ID: 31221253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
    Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
    Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin receptor blockers and outcomes in real-world older patients with heart failure and preserved ejection fraction: a propensity-matched inception cohort clinical effectiveness study.
    Patel K; Fonarow GC; Kitzman DW; Aban IB; Love TE; Allman RM; Gheorghiade M; Ahmed A
    Eur J Heart Fail; 2012 Oct; 14(10):1179-88. PubMed ID: 22759445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxin Use and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
    Qamer SZ; Malik A; Bayoumi E; Lam PH; Singh S; Packer M; Kanonidis IE; Morgan CJ; Abdelmawgoud A; Allman RM; Fonarow GC; Ahmed A
    Am J Med; 2019 Nov; 132(11):1311-1319. PubMed ID: 31150644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Race/Ethnic Differences in Outcomes Among Hospitalized Medicare Patients With Heart Failure and Preserved Ejection Fraction.
    Ziaeian B; Heidenreich PA; Xu H; DeVore AD; Matsouaka RA; Hernandez AF; Bhatt DL; Yancy CW; Fonarow GC
    JACC Heart Fail; 2017 Jul; 5(7):483-493. PubMed ID: 28501527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction.
    Park CS; Park JJ; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    J Am Heart Assoc; 2019 Mar; 8(6):e011077. PubMed ID: 30845873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional mitral regurgitation at discharge and outcomes in patients hospitalized for acute decompensated heart failure with a preserved or reduced ejection fraction.
    Kajimoto K; Sato N; Takano T;
    Eur J Heart Fail; 2016 Aug; 18(8):1051-9. PubMed ID: 27212582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
    Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
    Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Son MK; Park JJ; Lim NK; Kim WH; Choi DJ
    Heart; 2020 Aug; 106(15):1160-1168. PubMed ID: 32341140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Blockers and 1-Year Postdischarge Mortality for Heart Failure and Reduced Ejection Fraction and Slow Discharge Heart Rate.
    Park JJ; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    J Am Heart Assoc; 2019 Feb; 8(4):e011121. PubMed ID: 30755071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between atrial fibrillation and early outcomes of patients with heart failure and reduced or preserved ejection fraction.
    Eapen ZJ; Greiner MA; Fonarow GC; Yuan Z; Mills RM; Hernandez AF; Curtis LH
    Am Heart J; 2014 Mar; 167(3):369-375.e2. PubMed ID: 24576522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiation of anti-hypertensive drugs and outcomes in patients with heart failure with preserved ejection fraction and persistent hypertension.
    Lam PH; Tsimploulis A; Patel S; Raman VK; Arundel C; Faselis C; Deedwania P; Sheikh FH; Banerjee SK; Allman RM; Fonarow GC; Aronow WS; Ahmed A
    Prog Cardiovasc Dis; 2022; 73():17-23. PubMed ID: 35777433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone antagonists and outcomes in real-world older patients with heart failure and preserved ejection fraction.
    Patel K; Fonarow GC; Kitzman DW; Aban IB; Love TE; Allman RM; Gheorghiade M; Ahmed A
    JACC Heart Fail; 2013 Feb; 1(1):40-7. PubMed ID: 23814702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.